CIMdata PLM Industry Summary Online Archive
March 2011
Events tNews
SMi Presents their 6th Conference on Pharmaceutical Portfolio & Product Life-Cycle Management 29-30 June 2011, London, UK
As product pipelines become thinner, and pressure to get the most out of dwindling resources increases, pharmaceutical portfolio and product lifecycle management becomes an imperative part of a company’s approach to maximizing ROI. Not only must managers carefully strategize in relation to the product’s strengths against competitors and also in such a way to compliment the overall company portfolio, but they must also balance the crucial factors of regulatory change in patent protection, risk mitigation, effective R&D resource allocation in order to achieve an integrated approach to effective portfolio and PLCM.
Now in its 6th year, SMi Groups Pharmaceutical Portfolio & Product Life-Cycle Management is a meeting ground for such managers and directors who are faced with the task of managing the pipeline in a way that acknowledges the above mentioned factors and more. You can expect to discuss with some of the leading professionals in the field the best way to approach this difficult task. In a showcase of effective approaches from many of the largest pharmaceutical companies, you can be sure to learn much of value to yourself, and to your organization.
At this conference you will:
Discuss other’s approaches to fully integrated portfolio and PLCM management
Learn of the latest EU patent regulatory guidance
Analyse the most effective risk mitigation strategies
Debate the merits and drawbacks of portfolio out licensing
Network with our expert speaker line up
Make sure you save the date for our half day pre-conference workshop
Associated with the conference there will be a half-day interactive workshop on:
'Tools and Techniques for Optimal Drug Development Portfolio Planning: Portfolio Selection, Resource Allocation, and Risk Mitigation' taking place on Tuesday 28th of July. Leading this workshop will be Vladimir Shnaydman, President, ORBee Consulting
Confirmed Speaker include:
Ulrich Betz, Director, Department Head Center of Innovation, Merck Serono
Carmel Egan, Vice President, Project Management, Eli Lilly
Julie Barret-Major, Director of Intellectual Property, Norgine
Alessio Merlin, Director Strategic Planning, Bayer
Hans Hoogkamer, Business and Science Affairs, Actelion Pharmaceuticals
Tim Harris, Director, Respiratory & Immuno-inflammation Portfolio Management, GSK
Marie Bernasconi, Global Program Team Director, Novartis
Arif Shivji, Director, Pfizer
Fabio Domanico, Case Handler, European Pharmaceuticals Sector Task Force, DG Competition, European Commission
Kerstin Bode-Greuel, Lecturer, University of Essen/PME Institute
Michael O'Grady, Portfolio-Analysis Manager, GlaxoSmithKline
Mike Rea, Chief Executive Officer, IDEA Pharma
Sakir Mutevelic, Head of Global Project Management Biopharmaceuticals Hemophilia A / VWD, Baxter
Elisabeth Berthet, Lawyer at the Paris Bar, Armengaud-Guerlain
Kimber Hardy, Head of Valuation and Analysis, Portfolio Management , Merck Serono
For more information and to download the brochure visit http://www.smi-online.co.uk/pharma-portfolio12.asp or alternatively contact Zain Philbey on tel: +44 (0) 20 7827 6722 or email: zphilbey@smi-online.co.uk
Book before Thursday 31st March 2011 and receive an early bird discount of £100.
Become a member of the CIMdata PLM Community to receive your daily PLM news and much more.
Tell us what you think of the CIMdata Newsletter. Send your feedback.
CIMdata is committed to your privacy. Your personal information will never be sold or shared outside of CIMdata without your express permission.